Regenimo Biosciences, Inc. — Form D

Regenimo Biosciences, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-25. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2025-11-25
• Form: D
• Accession: 0002096367-25-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $2.0M
• Minimum investment: $50K
• Investors: 6
• Date of first sale: 2025-11-10
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-564953

Issuer

• Name: Regenimo Biosciences, Inc.
• CIK: 0002096367
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2025
• Address: 3262 WESTHEIMER RD. #762, HOUSTON, TX, 77098
• Phone: 7137022100

Officers, directors & promoters (4)

More

• CIK 2096367 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search